Navigation Links
Boston Scientific Platinum Chromium ION™ Stent Demonstrates Positive Outcomes in PERSEUS Clinical Program
Date:11/8/2011

NATICK, Mass. and SAN FRANCISCO, Nov. 8, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) reports positive long-term data from the PERSEUS clinical program, which demonstrated favorable two-year safety and effectiveness outcomes for the ION™ (TAXUS Element) Paclitaxel-Eluting Platinum Chromium Stent System versus prior-generation paclitaxel-eluting stents.  Results were presented today by PERSEUS clinical program Principal Investigators Louis Cannon, M.D., of the Cardiac and Vascular Research Center of Northern Michigan in Petoskey, Michigan, and Dean Kereiakes, M.D., Medical Director at The Christ Hospital Heart and Vascular Center and The Lindner Research Center in Cincinnati, at the Cardiovascular Research Foundation's annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in San Francisco.

"The PERSEUS trials build on the extensive TAXUS clinical program and extend the consistent outcomes seen with prior-generation paclitaxel stents to the platinum chromium ION Stent platform," said Dr. Cannon.  "The excellent clinical results at two years confirm the ION Stent's safety and efficacy in workhorse lesions and suggest superior performance relative to bare-metal stents in small vessels.  In addition, I have found the new alloy and stent design to offer increased flexibility, visibility and deliverability."

PERSEUS Workhorse and Small Vessel TrialsDr. Cannon presented results from the prospective, randomized pivotal PERSEUS Workhorse trial, which demonstrated comparable safety and efficacy at two years for the ION Stent compared to the Boston Scientific TAXUS® Express® Stent in more than 1,200 patients with de novo workhorse lesions.  Both stents showed similar rates of composite measures for target lesion failure (TLF) and major adverse cardiac events (MACE).  Ind
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Boston College Researchers discover 2 early stages of carbon nanotube growth
2. Building, Validating & Maintaining Controlled Environment Facilities is Focus of Oct. 18th Seminar in Boston Hosted by Microtest Laboratories
3. Boston Scientific Launches Neuromodulation Learning Institute To Enhance Clinical Education For Spinal Cord Stimulation
4. Genethon and Childrens Hospital Boston Get FDA approval for a Wiskott Aldrich Gene Therapy Trial
5. SynapDx Corporation Licenses Autism Diagnostic Discoveries From Childrens Hospital Boston
6. Boston Scientific to Webcast Conference Call Discussing First Quarter 2011 Financial Results
7. Boston College receives W.M. Keck Foundation funding for nanoscale optical microscope
8. Boston Scientific Acquires Intelect Medical
9. Boston Scientific Begins Patient Enrollment in Clinical Trial Assessing Deep Brain Stimulation for Parkinsons Disease
10. Boston College physics professor Willie Padilla receives PECASE award
11. Stryker Announces Definitive Agreement to Acquire the Neurovascular Division of Boston Scientific for $1.5 Billion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... Outside GC, the leading provider of ... of Debbie Casey as a member of the firm, ... , Debbie has spent over 20 years ... Medical Care North America in both legal and business ... work with Outside GC’s growing list of healthcare clients, ...
(Date:2/27/2015)... and SUMMERLAND, British Columbia , ... XON ), a leader in synthetic biology, ... acquire  Okanagan Specialty Fruits (OSF), the pioneering agricultural ... the world,s first non-browning apple. Through the acquisition, Intrexon ... that is more appetizing and convenient for consumers while ...
(Date:2/27/2015)... 2015 Immunovaccine Inc. (“Immunovaccine”) (TSX: ... today announced that the U.S. Food and Drug ... designation and Phase I clinical trials of the ... mutual co-development agreement signed with Gilead Life Sciences. ... for the DPX-Survivac. , “We have been in ...
(Date:2/27/2015)... 27, 2015 FamilyFarms Group is pleased ... of State Line Farms, received the 2015 Tomorrow’s Top ... under the age of 35, who has demonstrated excellence ... honor to win the Tomorrow's Top Producer Horizon Award. ... the Top Producer Award and learning from their experiences. ...
Breaking Biology Technology:Outside GC Expands Healthcare Team 2Intrexon to Acquire Okanagan Specialty Fruits 2Intrexon to Acquire Okanagan Specialty Fruits 3Intrexon to Acquire Okanagan Specialty Fruits 4Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3Matt Sims Receives the 2015 Tomorrow’s Top Producer Horizon Award 2
... Feb. 4 Patients with frequently,relapsing bipolar disorder ... an,initial relapse when risperidone long-acting injection (RLAI) was ... The study compared,patients who received RLAI and standard ... placebo., The study was presented yesterday at ...
... 4 Ardea Biosciences,Inc. (Nasdaq: RDEA ) today ... Advisory Board (SAB) with the,appointment of seven members, chaired ... scientific advice and counsel to the Company regarding,key decisions ... "Establishing a strong scientific advisory board for our ...
... 4 Uroplasty, Inc. (Amex:,UPI) announced today that ... of fiscal 2008 ended December 31, 2007, before ... Company will host a conference call to,discuss these ... a.m. Central,Time. David Kaysen, President and Chief Executive ...
Cached Biology Technology:Study Suggests Risperidone Long-Acting Injection Combined with Standard Treatment Helped Delay Time to Relapse in Patients with Bipolar Disorder 2Study Suggests Risperidone Long-Acting Injection Combined with Standard Treatment Helped Delay Time to Relapse in Patients with Bipolar Disorder 3Study Suggests Risperidone Long-Acting Injection Combined with Standard Treatment Helped Delay Time to Relapse in Patients with Bipolar Disorder 4Study Suggests Risperidone Long-Acting Injection Combined with Standard Treatment Helped Delay Time to Relapse in Patients with Bipolar Disorder 5Ardea Biosciences Establishes Scientific Advisory Board for HIV Program 2Ardea Biosciences Establishes Scientific Advisory Board for HIV Program 3Ardea Biosciences Establishes Scientific Advisory Board for HIV Program 4
(Date:2/24/2015)... , Feb. 24, 2015 This report analyzes the worldwide ... following Segments: Face Biometrics, and Voice Biometrics. The report provides separate ... Japan , Europe , ... Africa , and Latin America . ... 2020. Also, a seven-year historic analysis is provided for these markets. ...
(Date:2/19/2015)... 2015 Research and Markets ( ... "Military Electro-Optical / Infrared Systems Market by ... - Forecast to 2020" report to their ... market is expected to reach $16.35 billion by ... This report segments the military electro-optical/infrared systems ...
(Date:2/12/2015)... MINNETONKA, Minn. , Feb. 12, 2015 /PRNewswire/ ... technology company specializing in clinical study management systems, ... Partner Program , further distinguishing iMedNet ... for Clinical Research Organizations (CROs) and healthcare consultants.  ... sales support, prospective customer referrals and numerous co-marketing ...
Breaking Biology News(10 mins):World Face and Voice Biometrics Industry 2World Face and Voice Biometrics Industry 3World Face and Voice Biometrics Industry 4World Face and Voice Biometrics Industry 5World Face and Voice Biometrics Industry 6World Face and Voice Biometrics Industry 7World Face and Voice Biometrics Industry 8World Face and Voice Biometrics Industry 9World Face and Voice Biometrics Industry 10World Face and Voice Biometrics Industry 11World Face and Voice Biometrics Industry 12World Face and Voice Biometrics Industry 13World Face and Voice Biometrics Industry 14World Face and Voice Biometrics Industry 15World Face and Voice Biometrics Industry 16Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 2Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 3MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2
... in some living animal groups today has taken on ... evidence shows the feature is at least 100 million ... Munich (Germany), has led an international team of scientists, ... Their research has revealed fossilised evidence for reproduction using ...
... at Oregon State University recently completed the largest animal study ... challenge some basic concepts about how to determine what level ... study found that acceptable levels of at least one carcinogen ... believed. It also indicates that for many purposes trout may ...
... Conservation Society (WCS) announced today a major breakthrough in the ... According to the study, researchers will be able to ... from the unique DNA signature found in their dung. ... samples from tigers that were darted and sedated. The ...
Cached Biology News:Size did matter 2Improved method developed to test carcinogen risk 2Improved method developed to test carcinogen risk 3The straight poop on counting tigers 2
... Maximize the value of your microarray ... offer the support you need from ... the most up to date methods. ... the Gene Expression Profiling Service or ...
Formula variant: With macro- and micronutrients. Physical Form: powder Suitab tst: plant cell culture tested...
BD Falcon 850 cm Smooth-surface TufRol Roller Bottle, tissue-culture treated polystyrene, blow-molded one-piece design, with easy on/off non-vented cap, packed in double bag. (20/ca) Packaging: ...
... The Yeast Protein Kit is a simple ... of yeast cells. The kit has been optimized ... but can be used for any fungus species ... The Zymolyase digestion procedure effectively generates spheroplasts of ...
Biology Products: